Stimlabs LLC
ROSWELL, GA · CIK 0001900728 · Medtech · Private
Allograft and extracellular matrix (ECM) devices for advanced wound healing
stimlabs.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $10M
- 1 Form D · Dec 2021
- 57 months since last filing
- Contracts
- $10K
- 1 award · Veterans Affairs
- #629 of 4531 in medtech
- Patents
- 26
- 9 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Veterans Affairs · Graft | $10,400 | |
| Private capital raised | Form D · SEC | $10,000,000 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 626 | MIYAZAKI ENTERPRISES LLC | $11K | — |
| 627 | PROPRIA LLC | $11K | $574K |
| 628 | DuraStat LLC | $11K | $6.8M |
| 629 | Stimlabs LLC | $10K | $10M |
| 630 | CREOSALUS INC. | $10K | — |
| 631 | ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC | $10K | — |
| 632 | InCellDx, Inc. | $10K | $9.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John DanielDirector
Patents
- Translucent, Dehydrated Placental Tissue and Methods of Producing and Using the Sameapplication
- Compositions Derived from Placenta and Methods of Producing the Samegranted
- Compositions Derived from Placenta and Methods of Producing the Sameapplication
- Keratin Protein Extracts, Compositions, Methods and Uses Thereofapplication
- Translucent, Dehydrated Placental Tissue and Methods of Producing and Using the Samegranted
- Compositions Derived from Placenta and Methods of Producing the Sameapplication
- Compositions Derived From Placenta And Methods Of Producing The Samegranted
- Translucent, Dehydrated Placental Tissue and Methods of Producing and Using the Samegranted
- Translucent, Dehydrated Placental Tissue and Methods of Producing and Using the Samegranted
- Products Derived from Amniotic Fluid and Methods of Useapplication
- Compositions Derived from Placenta and Methods of Producing the Sameapplication
- Products Derived From Amniotic Fluid And Methods Of Usegranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.